Article metrics

Download PDFPDF

347 KEYNOTE-365 cohort C: pembrolizumab + enzalutamide in patients with abiraterone acetate–pretreated metastatic castration-resistant prostate cancer (mCRPC)—data after minimum of 22 months of follow-up
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to January 2024

AbstractFullPdf
Nov 2021196026
Dec 202180013
Jan 2022108018
Feb 202294016
Mar 2022250010
Apr 202296018
May 202276023
Jun 20225206
Jul 202260010
Aug 202290012
Sep 20226609
Oct 20227408
Nov 202248011
Dec 20226806
Jan 20235206
Feb 202370010
Mar 20235403
Apr 20232403
May 20231802
Jun 20231803
Jul 20232806
Aug 20234404
Sep 20234007
Oct 20233602
Nov 20233002
Dec 20233802
Jan 20241602
Total18260238